See also this year's filing and all EDGAR filings for this company.
PDF Report 0001503802_2022_Karyopharm_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001503802, Karyopharm Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 275,606,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,642,000 |
| 3 | remainder_Assets | 28,057,000 |
| 4 | LiabilitiesCurrent | 73,718,000 |
| 5 | LiabilitiesNoncurrent | 8,969,000 |
| 6 | remainder_Liabilities | 302,291,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 178,416,524 |
| 9 | ResearchAndDevelopmentExpense | 160,471,467 |
| 10 | remainder_Expenses | 3,908,733 |
| 11 | remainder_Revenues | 717,852,950 |
| 12 | remainder_NetIncome | -27,443,956 |
| 13 | remainder_ComprehensiveNetIncome | 162,650 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 305,305,000 |
| 1 | Liabilities | 384,978,000 |
| 2 | Expenses | 342,796,724 |
| 3 | Revenues | 717,852,950 |
| 4 | StockholdersEquity | -79,673,000 |
| 5 | NetIncome | 347,612,270 |
| 6 | ComprehensiveNetIncome | 347,693,595 |
| 7 | BaseVar | 889,269,640 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.504 |
| 9 | EconomicCapitalRatio | 1.89 |
Edgar->Model Mapping
Feature Distribution
Change over Time
